Question 1

What is the catalog number for RPL37 siRNA (Rat)?

Accepted Answer

The catalog number for RPL37 siRNA (Rat) is MBS8233381.

Question 2

What sizes are available for RPL37 siRNA (Rat)?

Accepted Answer

RPL37 siRNA (Rat) is available in the following size(s): 15 nmol, 30 nmol, 5x 30 nmol.

Question 3

How many pack sizes does RPL37 siRNA (Rat) come in?

Accepted Answer

RPL37 siRNA (Rat) is available in 3 different pack sizes.

Question 4

Is RPL37 siRNA (Rat) in stock?

Accepted Answer

RPL37 siRNA (Rat) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 7

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

RPL37 siRNA (Rat)

Product Specifications

Gene Name

NCBI Gene ID

Reactivity

Storage Conditions

Specificity

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

NCBI GB Accession Number

Uniprot Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

Frozen Tissue Sections, Prostate

Human VEGF-A (Vascular Endothelial Cell Growth Factor A) ELISA Kit

Human VEGF-A (Vascular Endothelial Cell Growth Factor A) ELISA Kit

Human VEGF-A (Vascular Endothelial Cell Growth Factor A) ELISA Kit

SLC12A4 Human Gene Knockout Kit (CRISPR)

Cytokeratin 8 (KRT8) Mouse Monoclonal Antibody [Clone ID: K8.8]